John G Ullman & Associates Inc Jazz Pharmaceuticals PLC Transaction History
John G Ullman & Associates Inc
- $630 Million
- Q1 2024
A detailed history of John G Ullman & Associates Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, John G Ullman & Associates Inc holds 30,150 shares of JAZZ stock, worth $3.17 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
30,150Holding current value
$3.17 Million% of portfolio
0.58%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
513Shares Held
57MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$743 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$678 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$259 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$250 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$157 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.59B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...